Serum Tenascin-C is independently associated with increased...

Archives of Cardiovascular Diseases Supplements 2020 / 01 Vol. 12; Iss. 1

Serum Tenascin-C is independently associated with increased major adverse cardiovascular events and death in patients with type II diabetes

Gellen, B., Thorin-Trescases, N., Thorin, E., Gand, E., Sosner, P., Brishoual, S., Fraty, M., Hadjadj, S., Saulnier, P.J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Journal:
Archives of Cardiovascular Diseases Supplements
DOI:
10.1016/j.acvdsp.2019.09.322
Date:
January, 2020
File:
PDF, 173 KB
2020
Conversion to is in progress
Conversion to is failed